Europe Sarcopenia Treatment Market Forecast to 2030

At 5.0% CAGR, Europe Sarcopenia Treatment Market is Speculated to be Worth US$ 1,467.81 Million by 2030, says the Research Team

According to the Research Team’ research, the Europe sarcopenia treatment market was valued at US$ 993.46 million in 2022 and is expected to reach US$ 1,467.81 million by 2030, registering a CAGR of 5.0% from 2022 to 2030. Products in clinical trial phases and rising awareness about sarcopenia are among the critical factors attributed to drive the Europe sarcopenia treatment market growth.

A few major players operating in the sarcopenia treatment market are increasingly focusing on drug development to treat sarcopenia. Novel sarcopenia treatments are currently being developed and tested in clinical trials. A few of these products are mentioned below:

Table 1. Sarcopenia Drug Under Clinical Development

Company Name Interventions Conditions Clinical Trial Stage

Abbott Nutrition Medical Food with AN777

Oral Nutritional Formula Malnutrition

Sarcopenia PHASE3

Nutricia Research Dietary Supplement: Bolus ONS A

Dietary Supplement: Bolus ONS B

Dietary Supplement: Bolus ONS C

Dietary Supplement: Bolus ONS D Sarcopenia PHASE1

Novartis Pharmaceuticals Drug: Bimagrumab Sarcopenia PHASE2

McMaster University Behavioural: Step Reduction Sarcopenia PHASE1

Metabolic Technologies Inc. Dietary Supplement: Placebo

Drug: HMB Plus Vitamin D

Behavioural: Non-Exercise

Behavioural: Exercise Sarcopenia PHASE1

Merck Sharp & Dohme LLC Drug: Comparator MK-077

Drug: Comparator Placebo Sarcopenia PHASE2

Immunotec Inc. Dietary Supplement: Immunocal

Dietary Supplement: Casein Aging and Sarcopenia PHASE2

Lijun Yang Combination Product: 3-Month Intensive Intervention Sarcopenia PHASE4

Regeneron Pharmaceuticals Drug: REGN1033 (SAR391786)

Drug: Placebo Sarcopenia PHASE2

Source: Company Websites and The the Reporting Teams Analysis

Therefore, the extending pipeline of drugs that are in different stages of clinical development presents significant opportunities for the sarcopenia treatment market growth.

On the contrary, unavailability of direct interventions hampers the growth of Europe sarcopenia treatment market.

Based on treatment type, the Europe sarcopenia treatment market is segmented into vitamin D and calcium supplement, protein supplement, vitamin B12 supplement, and others. The vitamin D and calcium supplement segment held 41.5% share of Europe sarcopenia treatment market in 2022, amassing US$ 412.46 million. It is projected to garner US$ 650.67 million by 2030 to register 5.9% CAGR during 2022-2030.

In terms of distribution channel, the Europe sarcopenia treatment market is segmented into pharmacies, retail channels, online channels, and others. The pharmacies segment held 39.4% share of Europe sarcopenia treatment market in 2022, amassing US$ 391.20 million. It is anticipated to garner US$ 555.67 million by 2030 to expand at 4.5% CAGR during 2022-2030.

Based on country, the Europe sarcopenia treatment market is categorized into Germany, France, Italy, the UK, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 28.1% share of Europe sarcopenia treatment market in 2022. It was assessed at US$ 279.26 million in 2022 and is likely to hit US$ 431.39 million by 2030, registering a CAGR of 5.6% during 2022-2030.

Key players operating in the Europe sarcopenia treatment market are Abbott Laboratories, Amway Corp, Bayer AG, GSK Plc, Metagenics LLC, Nestle Health Science SA, Novartis AG, Pfizer Inc, and Sanofi SA, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe sarcopenia treatment market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Europe sarcopenia treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe sarcopenia treatment market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Sarcopenia Treatment Market – Key Industry Dynamics
4.1 Europe Sarcopenia Treatment Market – Key Industry Dynamics
4.2 Market Drivers
4.2.1 Upsurge in Geriatric Population
4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
4.3 Key Market Restraints:
4.3.1 Unavailability of Direct Interventions
4.4 Key Market Opportunities:
4.4.1 Products in Clinical Trial Phases
4.5 Future Trends:
4.5.1 Rising Awareness About Sarcopenia
4.6 Impact of Drivers and Restraints:
5. Sarcopenia Treatment Market – Europe Market Analysis
5.1 Europe Sarcopenia Treatment Market Revenue (US$ Million), 2020 – 2030
5.2 Europe Sarcopenia Treatment Market Forecast and Analysis
6. Europe Sarcopenia Treatment Market Analysis – By Treatment Type
6.1 Vitamin D and Calcium Supplement
6.1.1 Overview
6.1.2 Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Protein Supplement
6.2.1 Overview
6.2.2 Protein Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.3 Vitamin B12 Supplement
6.3.1 Overview
6.3.2 Vitamin B12 Supplement: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7. Europe Sarcopenia Treatment Market Analysis – By Distribution Channel
7.1 Pharmacies
7.1.1 Overview
7.1.2 Pharmacies : Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
7.2 Retail Channels
7.2.1 Overview
7.2.2 Retail Channels : Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Online Channels
7.3.1 Overview
7.3.2 Online Channels : Europe Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others : Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
8. Europe Sarcopenia Treatment Market – Country Analysis
8.1 Europe
8.1.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Country
8.1.1.1 Europe Sarcopenia Treatment Market Revenue and Forecast and Analysis – By Country
8.1.1.2 Germany Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.2.1 Germany Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.2.2 Germany Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.3 France Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.3.1 France Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.3.2 France Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.4 United Kingdom Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.4.1 United Kingdom Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.4.2 United Kingdom Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.5 Italy Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.5.1 Italy Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.5.2 Italy Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.6 Spain Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.6.1 Spain Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.6.2 Spain Sarcopenia Treatment Market Breakdown by Distribution Channel
8.1.1.7 Rest of Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
8.1.1.7.1 Rest of Europe Sarcopenia Treatment Market Breakdown by Treatment Type
8.1.1.7.2 Rest of Europe Sarcopenia Treatment Market Breakdown by Distribution Channel
9. Sarcopenia Treatment Market-Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Sarcopenia Treatment Market
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Organic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Bayer AG
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Metagenics LLC
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Nestle Health Science SA
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Novartis AG
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Pfizer Inc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Sanofi SA
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Amway Corp
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 GSK Plc
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
11. Appendix
11.1 About The the Reporting Teams
11.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Sarcopenia Treatment Market Segmentation
Table 2. Sarcopenia Drug Under Clinical Development
Table 3. Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Million)
Table 4. Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Million) – By Treatment Type
Table 5. Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Million) – By Distribution Channel
Table 6. Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Country
Table 7. Germany Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 8. Germany Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 9. France Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 10. France Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 11. United Kingdom Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 12. United Kingdom Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 13. Italy Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 14. Italy Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 15. Spain Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 16. Spain Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 17. Rest of Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Treatment Type
Table 18. Rest of Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn) – By Distribution Channel
Table 19. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
Table 20. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
Table 21. Glossary of Terms, Sarcopenia Treatment Market

LIST OF FIGURES

Figure 1. Europe Sarcopenia Treatment Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Europe Sarcopenia Treatment Market Revenue (US$ Million), 2020 – 2030
Figure 4. Europe Sarcopenia Treatment Market Share (%) – By Treatment Type, 2022 and 2030
Figure 5. Vitamin D and Calcium Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Protein Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Vitamin B12 Supplement: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Others: Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 9. Europe Sarcopenia Treatment Market Share (%) – By Distribution Channel, 2022 and 2030
Figure 10. Pharmacies : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Retail Channels : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Online Channels : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. Others : Europe Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Europe Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
Figure 15. Europe Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 16. Germany Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 17. France Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 18. United Kingdom Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 19. Italy Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 20. Spain Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 21. Rest of Europe Sarcopenia Treatment Market – Revenue and Forecast to 2030(US$ Mn)
Figure 22. Growth Strategies in the Sarcopenia Treatment Market